Brain Tumor Clinical Trials
The Johnnie L. Cochran Brain Tumor Center is the coordination point for the physicians who specialize in clinical trials. The goal of the center is to shepherd basic research discoveries through patient trials and the government approval process. Researchers at Cedars-Sinai are racing to develop experimental treatments, and even vaccines, for fast-growing malignant tumors.
As a research facility, we often invite our patients to participate in clinical trials of new drugs and other therapies. The following links describe some of the cutting-edge research studies and clinical trials we are currently directing or have completed. For more information, visit our Research and Outcomes section.
- Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System
- 131I-TM-601 for Recurrent High Grade Glioma
- Gliadel and Dendritic Cell Vaccine for Malignant Tumors
- Immunotherapy for Glioblastoma and Brain Stem Glioma
- Bradmer Neuradiab Study for Glioblastoma
Dendritic Cell Vaccine Animation
For Windows Media Player, please click here.
For an appointment, a second opinion or more information, please call 1-800-CEDARS-1 (1-800-233-2771) or e-mail us.
